CML Advocacy: Learn. Share. Grow.
26-28 May 2017, Frankfurt, Germany
During the annual CML Horizons Conference on 26 to 28 May 2017 the CML Advocates Network welcomed 100 delegates (among them 24 newcomers) supporting patients and families affected by Chronic Myeloid Leukemia (CML) to Frankfurt, Germany. Delegates from around the world (Europe, North America, Asia, Africa, Middle East and Latin America) came to Frankfurt to learn from experts both medical and patient advocates on the latest information about CML, share best practices in patient advocacy in order to grow their organisations in their own countries and give back to their own communities. We also featured a poster board where our members were able to present some of their activities that they have had during the year. In addition to this our members had the opportunity to submit abstracts and feature in our “best Practice session” on a successful activity they had on their own country. Furthermore, at this year’s conference a new CML Horizons Steering Committee was elected.
CML Horizons is a wholly community-run and multi-sponsored conference, which has evolved from the “New Horizons” conferences 2002-2011. The annual conference is run by the CML Advocates Network, hosted by the non-profit, swiss-based and patient-driven “Leukemia Patient Advocates Foundation”.
Presentations, Photo Gallery and Videostreams are available now!
Click on “PDF” to see all presentations. If you wish to translate selected presentation, please contact Celia Marín at celia@lepaf.org and ask for the PowerPoint-file! This will make it easier for you to translate the presentation to the language of your choice.
Please note that the speakers have authorized CML Advocates Network only to provide the PDFs on this website, but it is not allowed to upload the PDFs somewhere else! So if you want to share the slides, please do this by linking to this page or the files on this site!
To stream individual sessions, click on “Webstream” below.
To check out the CML Horizons 2017 Photo Gallery, click HERE
CML Steering Committee
The programme has been governed by a global steering committee consisting of CML patient advocates from North America, Latin America, Asia and Pacific, Western Europe, Central and Eastern Europe & West Asia, Middle East and Africa. The CML Steering Committee 2016-2017 was:
- Giora Sharf (Israel, co-founder & permanent member of the Steering Committee)
- Jan Geissler (Germany, co-founder & permanent member of the Steering Committee)
- Jana Pelouchová (Czech Republic, co-founder & permanent member of the Steering Committee)
- Gail Sperling (USA, region North America)
- Bahija Gouimi (Morocco, region Africa & Middle East)
- Rita O. Christensen (Denmark, region Western Europe)
- Pat Garcia-Gonzalez (USA, elected representative region Latin America)
- Rod Padua (Philippines, region Asia-Pacific)
- Jelena Cugurovic (Serbia, region Central and Eastern Europe & West Asia)
The new CML Horizons Steering Committee elected during the CML Horizons 2017 conference and appointed for the period 2018-2019 consists of the following representatives:
- Giora Sharf (Israel, co-founder & permanent member of the Steering Committee)
- Jan Geissler (Germany, co-founder & permanent member of the Steering Committee)
- Jana Pelouchová (Czech Republic, co-founder & permanent member of the Steering Committee)
- Gail Sperling (USA, elected representative region North America)
- Ferdinand Mwangura (Kenya, elected representative region Africa & Middle East)
- Zack Pemberton-Whiteley (United Kingdom, elected representative region Western Europe)
- Sarunas Narbutas (Lithuania, elected representative region Central and Eastern Europe & West Asia)
- Mercedes Arteaga (USA, elected representative region Latin America)
- Rod Padua (Philippines, elected representative region Asia-Pacific)
For any questions regarding the conference, please contact Celia Marín celia@lepaf.org Lidija Pecova lidija@lepaf.org
Sponsorship Acknowledgement
We would like to thank the following organisations for providing unconditional educational funding. Without their support, this conference would not be possible:
- Novartis Oncology (Initiating platinum sponsor)
- Bristol-Myers Squibb (Gold Sponsor)
- Pfizer Oncology (Gold Sponsor)
- Incyte (Gold Sponsor)
- Takeda Oncology (Silver Sponsor)
- The Leukemia & Lymphoma Society (Bronze Sponsor)
- International CML Foundation (Bronze Sponsor)